Genomic & Biopharma NewsNew cancer cell line range introduced by AMSBIO
AMSBIO has introduced a new range of cancer cell line models and culture media for the most difficult to culture tumor types where no models may exist.
|News Medical Life Sciences, 2017-02-16 10:01:55|
Making single-cell RNA sequencing widely available
Portable tool could help scientists learn more about cells’ roles in many diseases. by Anne Trafton | MIT News Office Sequencing messenger RNA molecules from individual cells offers a glimpse into the lives of those cells, revealing what they’re doing at a particular time. However, the equipment required to do this kind of analysis is ...
|Transcriptome Research & Industry News, 2017-02-16 10:00:58|
Soon we’ll be able to spot diseases like cancer before we even feel sick
from The Gaurdian by Gustavo Stolovitzky – The sooner a disease is diagnosed, the more likely it is to be well managed or cured. The challenge to finding a disease early is that most of us don’t seek treatment until we have symptoms, which means the disease has already progressed. But breakthroughs in nanobiotechnology techniques ...
|Exosome RNA Research & Industry News, 2017-02-16 10:00:00|
Despite deaths and trial halts, Leerink sees Juno positives
Despite deaths and trial halts, Leerink sees Juno positives badams Thu, 02/16/2017 - 04:39
|Fierce Biotech, 2017-02-16 09:39:46|
Coulometric low bromine index determination explored in new white paper by Mettler Toledo
The bromine index (BI) is the fraction of reactive unsaturated compounds in hydrocarbons encountered in the petrochemical industry. To determine low BI using coulometric titration, low generation currents are required according to ASTM D1494.
|News Medical Life Sciences, 2017-02-16 09:38:00|
Product to assist bone formation in spinal fusion surgery released by DePuy Synthes
DePuy Synthes*, in collaboration with LifeNet Health®, launches ViviGen Formable™ Cellular Bone Matrix**, a second generation cellular allograft used to assist in the formation of bone during spinal fusion surgery. ViviGen Formable augments the DePuy Synthes biomaterials portfolio and joins the first generation, ViviGen® Cellular Bone Matrix, which launched in late 2014. With both ViviGen and ViviGen Formable, surgeons may now choose a preferred handling option based on the needs of each surgical case.
|News Medical Life Sciences, 2017-02-16 09:28:27|
Microscope cameras with CMOS sensor and high acquisition speed released by Zeiss
ZEISS introduces two new digital microscope cameras; ZEISS Axiocam 702 mono and ZEISS Axiocam 512 color complement the current portfolio of high-speed USB 3.0 microscope cameras.
|News Medical Life Sciences, 2017-02-16 09:07:23|
Editas stock jumps after Broad wins CRISPR patent fight
Editas stock jumps after Broad wins CRISPR patent fight nick.paul.taylor Thu, 02/16/2017 - 03:41
|Fierce Biotech, 2017-02-16 08:41:21|
Experts establish first set of diagnostic criteria for life-threatening idiopathic multicentric CD
More than six decades after Castleman disease was first described, a group of experts from Penn Medicine and other institutions around the world has established the first set of diagnostic criteria for a life-threatening subtype of the condition, idiopathic multicentric CD, which is often misdiagnosed as other illnesses.
|News Medical Life Sciences, 2017-02-16 07:41:42|